Related Articles
Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss
Carnosol inhibits osteoclastogenesis <em>in vivo</em> and <em>in vitro</em> by blocking the RANKL‑induced NF‑κB signaling pathway Retraction in /10.3892/mmr.2024.13369
An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenesis in bone marrow‑derived macrophages
Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
Silk fibroin hydrolysate inhibits osteoclastogenesis and induces apoptosis of osteoclasts derived from RAW 264.7 cells